EJMK Ventures’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$306K Sell
1,892
-275
-13% -$45.8K 0.13% 124
2026
Q2
$411K Sell
2,167
-1,130
-34% -$213K 0.19% 93
2026
Q1
$650K Sell
3,297
-1,328
-29% -$256K 0.36% 51
2025
Q4
$850K Buy
+4,625
New +$811K 0.52% 46

Other funds holding AZN

EJMK Ventures's AZN Position: Q3 2026 in Review

EJMK Ventures reduced its AstraZeneca (AZN) stake by 13% in Q3 2026, selling an estimated $45.8K and leaving 1,892 shares worth $306K. The position accounts for 0.13% of the portfolio, ranked #124.

EJMK Ventures first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $850K in Q4 2025. 1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • EJMK Ventures held 1,892 shares of AstraZeneca worth $306K as of Q3 2026.
  • EJMK Ventures sold 275 AstraZeneca shares in Q3 2026, an estimated $45.8K.
  • AstraZeneca made up 0.13% of EJMK Ventures's portfolio in Q3 2026, its #124 holding.
  • EJMK Ventures first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • EJMK Ventures's AstraZeneca position peaked at $850K in Q4 2025.
  • 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.